Key facts
- This page summarizes David J. Borges's Form 4 filing for OMEROS CORP (OMER).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 24 Jul 2026, 21:11.
David J. Borges - 22 Jul 2026 Form 4 Insider Report for OMEROS CORP (OMER)
- Reporting relationship
- VP, Finance & CAO
- Issuer ticker
- OMER
- Reported as of
- 22 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Jul 2026, 21:11:31 UTC
- Prior SEC filing
- 14 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter B. Cancelmo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David J. Borges filed Form 4 for OMEROS CORP (OMER) on 24 Jul 2026.
Change
- Previous filing in this sequence was filed on 14 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002005787
Primary reporting owner
Borges David J.
- Relationship
- VP, Finance & CAO
- Address
- 201 ELLIOTT AVENUE WEST, SEATTLE
- Signature
- /s/ Peter B. Cancelmo, Attorney-in-Fact
- Signature date
- 24 Jul 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMER
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +105,000
- Change %
- Price
- $0.000000*
- Shares after
- 105,000
- Date
- 22 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 105,000
- Exercise price
- $9.84
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter.